Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

Latest News

Wild night in Miami: Heat top Nuggets 149-141 in 2 OTs

Mar 20, 2018

MIAMI — James Johnson scored a career-high 31 points, Kelly Olynyk added 30 off the bench and the Miami Heat set a franchise single-game scoring record by beating the Denver Nuggets 149-141 in double overtime Monday night. Miami's total was also an NBA season-high and helped the Heat get back to the No. 7 spot in the Eastern Conference standings. Houston and Oklahoma City each scored 148 in games earlier this season. Wayne Ellington scored 29 points for the Heat. Nikola Jokic had 34 for Denver, while Wilson Chandler added 26 for the Nuggets. Neither team was at full strength....

Hardaway, Beasley lead Knicks past depleted Bulls, 110-92

Mar 20, 2018

NEW YORK — The Knicks have won two straight games for the first time in almost two months, and they're not apologizing for the caliber of their competition. Tim Hardaway Jr. scored 22 points and Michael Beasley added 17 as New York beat the depleted Chicago Bulls 110-92 on Monday night. "We don't care who they put out there," Beasley said. "They could put a bunch of toddlers out there. Once the game starts, the game starts." Enes Kanter had 10 points and 13 rebounds, while Troy Williams added 11 for the Knicks. Cristiano Felicio scored a career-high 17 points...

The Latest: Austin blast left victims 'bleeding profusely'

Mar 20, 2018

AUSTIN, Texas — The Latest on the bombings in Austin, Texas (all times local): 6:25 p.m. A relative of one of the latest Austin bombing victims says the blast left what appeared to be nails stuck below his grandson's knees. William Grote told The Associated Press on Monday that his grandson was cognizant but still in a lot of pain while remaining hospitalized. Police have not yet identified the victims of Sunday's explosion but Grote says his grandson was one of the two people hurt. Grote says one of them was riding a bike in the street and the other...

Embiid, Simmons lead 76ers past Hornets 108-94

Mar 20, 2018

PHILADELPHIA — With Allen Iverson watching from a suite, Joel Embiid produced yet another dominant game in a season where the 76ers' All-Star has barely practiced. Yes, Embiid is another Philly star who sits out practice. Unlike Iverson, whose complaints about practice are part of his legend, the suddenly sturdy 76ers big man takes extra rest with the full support of coach Brett Brown. Embiid had 25 points and 19 rebounds and Ben Simmons had a triple-double to lead Philadelphia to a 108-94 win over the Charlotte Hornets on Monday night. Simmons had 11 points, 12 rebounds, 15 assists and...

A-Rod: Yankees' "breathtaking" offense could break records

Mar 20, 2018

TAMPA, Fla. — Alex Rodriguez thinks the New York Yankees' "breathtaking" offense could break records this season. Rodriguez arrived at spring training Monday and had high praise for a lineup led by Giancarlo Stanton, Aaron Judge, Gary Sanchez and Didi Gregorius. A-Rod is a team special adviser who has worked with a number of New York's younger players. "Happy to be back and see so much talent," Rodriguez said Monday night. "It's breathtaking." The Yankees added Stanton, the NL MVP after hitting 59 homers and driving in 132 last season, in a December trade with Miami. Judge had 52 homers...

About Us

The Final Scoreboard has fast, accurate live scores for you. We provide premium online content from in-depth analysis to the scores and statistics across American and European Sports.

Contact us: sales[at]thefinalscoreboard.com

Subscribe Now!